4BASEBIO

4basebio-logo

4Basebio focuses on life science technology, DNA manufacturing, and supply DNA products to serve the fast-growing gene therapy market.

#SimilarOrganizations #People #Financial #Website #More

4BASEBIO

Industry:
Biotechnology Health Care Life Science Therapeutics

Founded:
1997-01-01

Address:
Heidelberg, Baden-Wurttemberg, Germany

Country:
Germany

Website Url:
http://www.4basebio.com

Total Employee:
101+

Status:
Active

Contact:
34 91 192 36 50

Total Funding:
299.2 K EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins Mobile Non Scaleable Content


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

Current Employees Featured

heikki-lanckriet_image

Heikki Lanckriet
Heikki Lanckriet Chief Executive Officer @ 4Basebio
Chief Executive Officer

Stock Details


Company's stock symbol is ETR:4BSB

Investors List

la-caixa-foundation_image

la Caixa Foundation

la Caixa Foundation investment in Grant - 4Basebio

Official Site Inspections

http://www.4basebio.com Semrush global rank: 6.63 M Semrush visits lastest month: 912

  • Host name: 198.49.23.144
  • IP address: 198.49.23.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "4Basebio"

4Basebio - Crunchbase Company Profile & Funding

When was the last funding round for 4Basebio? 4Basebio closed its last funding round on Jul 29, 2024 from a Post-IPO Equity round. Who are 4Basebio 's competitors? Alternatives and โ€ฆSee details»

4basebio | Drug Discovery News

The proprietary DNA products feed into the production of mRNA, viral vectors and DNA vaccine technologies. 4basebioโ€™s targeted, non-viral delivery platform, Hermesโ„ข, allows targeting โ€ฆSee details»

4basebio - The Org

4basebio is enabling next generation cell and gene therapies and vaccines with its technologies and solutions. We are able to design, manufacture and supply application-specific synthetic โ€ฆSee details»

4basebio (AIM:4BB) Company Profile & Description - Stock Analysis

May 22, 2025 4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions โ€ฆSee details»

4Basebio Company Profile - Office Locations, Competitors ... - Craft

4Basebio (formerly Expedeon) is a company that specializes in the manufacture and distribution of pharmaceutical grade DNA products. It offers DNA amplification kits, genome coverage โ€ฆSee details»

4basebio AG: Innovating Biochemical Solutions for โ€ฆ

Jan 29, 2021 4basebio reports on results of the Extraordinary General Meeting 2021. 28th January 2021. Release according to Article 40, Section 1 of the WpHG. 27th January 2021. Decision to make a public takeover offer to the โ€ฆSee details»

Synthetic DNA & mRNA Products | About | 4basebio

About. 4basebio (AIM: 4BB) is an innovation driven biotechnology company focused on accelerating the development of advanced therapy medicinal products (ATMPs) through its high-performance synthetic DNA products and non-viral, โ€ฆSee details»

4basebio - 2025 Company Profile, Funding & Competitors - Tracxn

May 18, 2025 4basebio is a public company based in Cambridge (United Kingdom), founded in 1997. It operates as a Developer of synthetic DNA and non-viral nanoparticles for delivering โ€ฆSee details»

4basebio Management Team | Org Chart - RocketReach

Top 4basebio Management Employees Amy Walker Vice President Research and Business Development at 4basebio London, GB View. 1 4basebio.com; 1 440122396XXXX; Francesca โ€ฆSee details»

4BASEBIO PLC overview - Find and update company information

More for 4BASEBIO PLC (13519889) Registered office address 25 Norman Way, Over, Cambridgeshire, CB24 5QE . Company status Active Company type Public limited Company โ€ฆSee details»

4Basebio - Funding, Financials, Valuation & Investors - Crunchbase

Their latest funding was raised on Jul 29, 2024 from a Post-IPO Equity round. 4Basebio is registered under the ticker ETR:4BSB . 4Basebio is funded by 4 investors. ... How much โ€ฆSee details»

4basebio - Enzyme engineering and manufacturing for Molecular ...

4basebio is the owner of registered trademark(s) and trademarks which are the subject of pending applications or which are otherwise protected by law. 4basebio trademarks must not be used โ€ฆSee details»

Available Positions | Join Our Team - 4basebio

4basebio is an innovative gene synthesis company with the ambition to provide high quality, synthetic DNA for use in gene therapy and gene editing platforms. The company is growing โ€ฆSee details»

4basebio : Form of Proxy 2025 | MarketScreener

2 days ago 4BASEBIO PLC ANNUAL GENERAL MEETING FORM OF PROXY I/We... 4basebio PLC is a United Kingdom-based biotechnology company. The Company is focused on life โ€ฆSee details»

Annual Report โ€“ 4basebio Investors

4basebio AG is the new name of Expedeon AG; its ticker symbol has changed to 4BSB from EXNN. 4basebio AG ist der neue Name der Expedeon AG; Das Tickersymbol wurde von โ€ฆSee details»

4Basebio - Contacts, Employees, Board Members, Advisors & Alumni

Organization. 4Basebio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Number of Board โ€ฆSee details»

London Stock Exchange | London Stock Exchange

May 27, 2024 London Stock Exchange | London Stock Exchange ... nullSee details»

4basebio (FRA:88Q) Company Profile & Description - Stock Analysis

Apr 29, 2025 4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions โ€ฆSee details»

mRNA Production | Leadership - 4basebio

He has a proven track record of global commercial strategy, driving growth and expanding market presence. Prior to joining 4basebio, he held executive leadership roles in both start-up and โ€ฆSee details»

4basebio expects to sustain DNA sales growth momentum in 2025

5 days ago (Alliance News) - 4basebio on Tuesday reported a wider pretax loss in 2024, despite higher revenue, and said it is optimistic about the year to come. The Cambridge, England โ€ฆSee details»

linkstock.net © 2022. All rights reserved